Literature DB >> 12871671

The glucagon-like peptides: a double-edged therapeutic sword?

TracyAnn Perry1, Nigel H Greig.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12871671     DOI： 10.1016/S0165-6147(03)00160-3

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  43 in total

Review 1.  Imaging in pancreatic disease.

Authors:  Julien Dimastromatteo; Teresa Brentnall; Kimberly A Kelly
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-11-09       Impact factor: 46.802

2.  Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice.

Authors:  David Tweedie; Lital Rachmany; Vardit Rubovitch; Elin Lehrmann; Yongqing Zhang; Kevin G Becker; Evelyn Perez; Jonathan Miller; Barry J Hoffer; Nigel H Greig; Chaim G Pick
Journal:  Exp Neurol       Date:  2012-10-08       Impact factor: 5.330

Review 3.  Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier.

Authors:  William A Banks
Journal:  Adv Drug Deliv Rev       Date:  2011-12-17       Impact factor: 15.470

4.  Novel GLP-1R/GIPR co-agonist "twincretin" is neuroprotective in cell and rodent models of mild traumatic brain injury.

Authors:  Ian A Tamargo; Miaad Bader; Yazhou Li; Seong-Jin Yu; Yun Wang; Konrad Talbot; Richard D DiMarchi; Chaim G Pick; Nigel H Greig
Journal:  Exp Neurol       Date:  2016-11-11       Impact factor: 5.330

5.  Oral delivery of glucagon like peptide-1 by a recombinant Lactococcus lactis.

Authors:  Payal Agarwal; Pulkit Khatri; Blasé Billack; Woon-Kai Low; Jun Shao
Journal:  Pharm Res       Date:  2014-06-14       Impact factor: 4.200

6.  Exendin-4 induced glucagon-like peptide-1 receptor activation reverses behavioral impairments of mild traumatic brain injury in mice.

Authors:  Lital Rachmany; David Tweedie; Yazhou Li; Vardit Rubovitch; Harold W Holloway; Jonathan Miller; Barry J Hoffer; Nigel H Greig; Chaim G Pick
Journal:  Age (Dordr)       Date:  2012-08-15

7.  Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury.

Authors:  Nigel H Greig; David Tweedie; Lital Rachmany; Yazhou Li; Vardit Rubovitch; Shaul Schreiber; Yung-Hsiao Chiang; Barry J Hoffer; Jonathan Miller; Debomoy K Lahiri; Kumar Sambamurti; Robert E Becker; Chaim G Pick
Journal:  Alzheimers Dement       Date:  2014-02       Impact factor: 21.566

8.  Blast traumatic brain injury-induced cognitive deficits are attenuated by preinjury or postinjury treatment with the glucagon-like peptide-1 receptor agonist, exendin-4.

Authors:  David Tweedie; Lital Rachmany; Vardit Rubovitch; Yazhou Li; Harold W Holloway; Elin Lehrmann; Yongqing Zhang; Kevin G Becker; Evelyn Perez; Barry J Hoffer; Chaim G Pick; Nigel H Greig
Journal:  Alzheimers Dement       Date:  2015-08-29       Impact factor: 21.566

9.  Liraglutide, a long-acting GLP-1 mimetic, and its metabolite attenuate inflammation after intracerebral hemorrhage.

Authors:  Jack Hou; Anatol Manaenko; Jakob Hakon; Jacob Hansen-Schwartz; Jiping Tang; John H Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2012-09-12       Impact factor: 6.200

10.  Glucagon-like peptide-1 functionalized PEG hydrogels promote survival and function of encapsulated pancreatic beta-cells.

Authors:  Chien-Chi Lin; Kristi S Anseth
Journal:  Biomacromolecules       Date:  2009-09-14       Impact factor: 6.988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.